Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891436 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Stefan Saremba0

Jörg Wischhusen0

Markus Junker0

Thomas Müller0

Date of Patent

February 6, 2024

0

Patent Application Number

169909290

Date Filed

August 11, 2020

0

Patent Citations

US Patent 10421807 Interleukin-31 monoclonal antibody

0

US Patent 11262360 GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

0

US Patent 10781251 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

0

US Patent 11464856 Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

0

US Patent 8003099 Antibodies against human IL17 and uses thereof

0

US Patent 9334331 Bispecific antibodies

0

Patent Primary Examiner

Elizabeth C. Kemmerer

0

Patent abstract

The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891436 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.